Related Experiment Video
Updated: Jun 19, 2026

04:02
System for Focal, Closed-System Central Nervous System Injury
Published on: November 29, 2024
Improved cost-effectiveness and efficiency with a slower shockwave delivery rate.
Vincent Koo1, Irene Beattie, Michael Young
1Stone Treatment Centre, Craigavon Area Hospital, Portadown, Northern Ireland, UK. vkoo76@gmail.com
BJU International
|November 6, 2009
Summary
Slowing extracorporeal shockwave lithotripsy (ESWL) shockwave delivery to 70 shocks/min significantly improves stone-free rates and treatment efficiency. This slower rate also halves the actual cost of ESWL for kidney stones.
Area of Science:
- Urology
- Nephrology
- Medical Devices
Background:
- Extracorporeal shockwave lithotripsy (ESWL) is a common treatment for kidney stones.
- Optimizing shockwave (SW) delivery rate is crucial for treatment efficiency and cost-effectiveness.
Purpose of the Study:
- To evaluate the impact of a slower SW delivery rate (70 shocks/min) on ESWL treatment efficiency and cost.
- To compare a slow SW rate with a faster rate (100 shocks/min) in a clinical setting.
Main Methods:
- A comparative study involving 102 patients with upper urinary tract radio-opaque calculi undergoing ESWL.
- Patients were divided into two groups: slow (70 SW/min) and fast (100 SW/min) SW delivery rates.
- Outcomes assessed included stone-free rate, re-treatment rate, additional procedures, and both perceived and actual costs over a > or = 6-month follow-up.
Main Results:
- The slow SW rate group demonstrated a significantly higher stone-free rate (67% vs 25.5%) and a lower re-treatment rate (22% vs 45%).
- Fewer mean shocks were required for clinical success in the slow group (3045 vs 4414), with a greater efficiency quotient (0.51 vs 0.16).
- The actual cost of treatment was significantly reduced by half in the slow group (496 pounds vs 1002 pounds).
Conclusions:
- Reducing the SW delivery rate to 70/min significantly enhances ESWL treatment efficiency.
- A slower SW delivery rate substantially decreases the overall cost of ESWL while improving clinical outcomes.

